A pharmacokinetic and pharmacodynamic evaluation of iclaprim activity against wild-type and corresponding thymidine kinase-deficient Staphylococcus aureus in a mouse abscess model

References

1. Hawser S. Differential Activity of Iclaprim and Trimethoprim Against Wild-Type and Thymidine Kinase-Deficient Staphylococcus aureus Mutants San Francisco, CA, USA: ICAAC; 2007
   [Google Scholar]
2. Koch AE, Burchall JJ. Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. Appl Microbiol 1971; 22:812–817[PubMed]
   [Google Scholar]
3. Nottebrock H, Then R. Thymidine concentrations in serum and urine of different animal species and man. Biochem Pharmacol 1977; 26:2175–2179 [View Article][PubMed]
   [Google Scholar]
4. Then R, Angehrn P. The biochemical basis of the antimicrobial action of sulfonamides and trimethoprim in vivo-I. Action of sulfonamides and trimethoprim in blood and urine. Biochem Pharmacol 1974; 23:2977–2982[PubMed]
   [Google Scholar]
5. Then R, Angehrn P. The biochemical basis of the antimicrobial action of sulfonamides and trimethoprim in vivo-II. Experiments on the limited thymine and thymidine availability in blood and urine. Biochem Pharmacol 1975; 24:1003–1006 [View Article][PubMed]
   [Google Scholar]
6. CLSI Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 10th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018 pp. M07-A11
   [Google Scholar]
7. Haldimann A, Hawser S, Bihr M, Fels S, Rigo S et al. Effect of Thymidine on the Activity of Diaminopyrimidine Antibacterial Agents: Generation and Characterization of Thmidine Kinase-Deficient Staphylococus auerius Mutants Washington, DC, USA: 46th ICAAC/ASM 2006; 2006
   [Google Scholar]
8. National Research Council of the National Academies Guide for the Care and Use of Laboratory Animals, 8th ed. Washington, DC: The National Academies Press; 2011
   [Google Scholar]
9. Leggett JE, Fantin B, Ebert S, Totsuka K, Vogelman B et al. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J Infect Dis 1989; 159:281–292 [View Article][PubMed]
   [Google Scholar]
10. Haldimann A, Fels S, Rigo S, Islam K, Lociuro S et al. Effect of Thymidine on the Activity of Diaminopyrimidine Antibacterial Agents: Generation and Characterization of Thymidine Kinase-Deficient Staphylococcus aureus Mutants Washington, DC, USA: 46th ICAAC/ASM 2006; 2006
    [Google Scholar]
11. Park JH, Craig W, Marchillo K, Huang DB, Andes DR. Identification of the In vivo pharmacokinetics and pharmacodynamic driver of iclaprim. Antimicrob Agents Chemother 2018; 62:e0255017 [View Article][PubMed]
    [Google Scholar]